Vaccine Adjuvant Market
- 2026 年市場規模
- USD 1.81 Bn
- 2033 年預估規模
- USD 2.13 Bn
- 年複合成長率 CAGR
- 2.34%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Vaccine Adjuvant Market, By Type (Mineral Salt-based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-derived Adjuvants, Virus-like Particles (VLP), and Other Types), By Usage (Active Immunostimulants, Carriers,), By Disease Type (Infectious Disease and Cancer), By Application (Research Applications and Commercial Applications), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)
報告摘要
An adjuvant is a vaccine component that boosts the immune response to the vaccine. An adjuvant is used to create a stronger immune response in people receiving the vaccine. In short, adjuvants help vaccines work better. Newer adjuvants have been developed to target specific components of the body’s immune response, so that protection against disease is stronger and lasts longer.
Market Dynamics
Rise in prevalence of chronic/infectious diseases, increasing use of vaccine adjuvants, government initiatives or policies for immunization, outbreak of COVID-19 (pandemic), and increase in focus on the development of safe and effective vaccine are major factors expected to drive growth of the global vaccine adjuvants market over the forecast period.
For instance, in October 2022, MHRP and collaborators recently launched a Phase 1 trial that will evaluate safety, tolerability, and immunogenicity of varying doses of the Army’s ALFQ adjuvant in a candidate HIV vaccine to optimize adjuvant dosage.
Furthermore, in August 2021, Medigen Vaccine Biologics Corporation and Dynavax Technologies Corporation announced the rollout of its COVID-19 vaccine, MVC-COV1901. More than 600,000 people are anticipated to receive the Medigen vaccine this week.
Key features of the study
• This report provides in-depth analysis of the global vaccine adjuvants market, and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global vaccine adjuvants market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Air Liquide (Seppic), Pacific GeneTech Limited, OZ Biosciences, Novavax Inc., Merck & Co. Inc., InvivoGen, GlaxoSmithKline PLC, Dynavax Technologies Corporation, CSL Limited, Croda International PLC, Vertellus, Aphios Corporation, Agenus Inc., Adjuvatis, and Associated British Foods PLC (SPI Pharma Inc.)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global vaccine adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaccine adjuvants market.
Market Segmentation
• By Type (Revenue, USD Bn, 2021-2033)
o Mineral Salt-based Adjuvant
o Tensoactive Adjuvants
o Adjuvant Emulsions
o Liposome Adjuvants
o Carbohydrate Adjuvants
o Bacteria-derived Adjuvants
o Virus-like Particles (VLP)
o Other Types
• By Usage (Revenue, USD Bn, 2021-2033)
o Active Immunostimulants
o Carriers
• By Disease Type (Revenue, USD Bn, 2021-2033)
o Infectious Disease
o Cancer
• By Application (Revenue, USD Bn, 2021-2033)
o Research Applications
o Commercial Applications
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Thermo Fisher Scientific Inc.
o Air Liquide (Seppic)
o Pacific GeneTech Limited
o OZ Biosciences, Novavax Inc.
o Merck & Co. Inc.
o InvivoGen
o GlaxoSmithKline PLC
o Dynavax Technologies Corporation
o CSL Limited
o Croda International PLC
o Vertellus
o Aphios Corporation
o Agenus Inc.
o Adjuvatis
o Associated British Foods PLC (SPI Pharma Inc.)
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Type
Market Snapshot, By Usage
Market Snapshot, By Disease Type
Market Snapshot, By Application
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Global Vaccine Adjuvant Market, By Type, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Mineral Salt-based Adjuvant
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Tensoactive Adjuvants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Adjuvant Emulsions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Liposome Adjuvants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Carbohydrate Adjuvants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Bacteria-derived Adjuvants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Virus-like Particles (VLP)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Other Types
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
5. Global Vaccine Adjuvant Market, By Usage, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Active Immunostimulants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Carriers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
6. Global Vaccine Adjuvant Market, By Disease Type, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Infectious Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
7. Global Vaccine Adjuvant Market, By Application, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Research Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Commercial Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
8. Global Vaccine Adjuvant Market, By Region, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
9. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Thermo Fisher Scientific Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Air Liquide (Seppic)
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Pacific GeneTech Limited
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
OZ Biosciences
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Novavax Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Merck & Co. Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
InvivoGen
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
GlaxoSmithKline PLC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Dynavax Technologies Corporation
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
CSL Limited
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Croda International PLC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Vertellus
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Aphios Corporation
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Agenus Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Adjuvatis
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Associated British Foods PLC (SPI Pharma Inc.)
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
10. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們